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Introduction
Reorganization of the actin cytoskeleton, focal adhesions, vesicle 
trafficking, cell movement and immunological processes such 
as phagocytosis or production of reactive oxygen species have 
fine temporal and spatial regulation by Rho family GTPases.1-3 
As molecular switches, small G-proteins are able to bind GTP, 
which turns them to an active state. After a slow hydrolysis of 
the terminal phosphate of GTP they go to an inactive, GDP-
bound form. These processes are regulated by 3 types of pro-
teins: guanine nucleotide exchange factors (GEFs), guanine 
nucleotide dissociation inhibitors (GDIs) and GTPase acti-
vating proteins (GAPs).4,5 GEFs facilitate the dissociation of 
GDP from GTPases thereby promoting the binding of GTP.6 
GDIs maintain small G-proteins in the GDP-bound, inactive 
state and regulate their subcellular distribution.7 GAPs increase 
the endogenous GTPase activity of small G-proteins up to five 
orders of magnitude thereby inactivating them.4,8 GAPs are vital 
in termination of biological signals9 but there are examples where 
inhibition of constitutive GAP activity significantly contributes 
to activation processes.9,10
The Ras superfamily contains more than a hundred small 
G-proteins which are classified into 5 subfamilies.11 One of them 
is the Rho family including the well-known members Rac, Rho 
and Cdc42 that are regulated by about 70 potential GAPs.5,12 
The common catalytic domain of Rho family GAPs is approx. 
150 amino acids in length and consists of 9 α-helices. It con-
tains a conserved arginine which is responsible for the catalytic 
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activity.13 Rho/Rac GAPs are also characterized by varied non-
catalytic domains which suggest their complex regulation, 
their specific localization in molecular complexes and their 
specific role in signaling pathways.14 Several physiological func-
tions are known to be regulated by Rho family GAPs such as 
embryogenesis,15,16 neural development,9,17 cytokinesis and 
differentiation.18,19 Lack of several Rho/Rac GAPs results in 
remarkable phenotype indicating their vital role in cellular 
regulation.9,20
The large number of Rho family GAPs raises the question 
of whether they show tissue-specific expression or they are 
characterized by overlapping tissue-distribution. The aim of 
the present study was to identify as many Rho family GAPs as 
possible and to investigate their tissue-distribution. However, 
GAP domain-containing proteins have very diverse nomencla-
ture which makes their identification difficult. In the case of 
Arf family GAPs, a consensus nomenclature has been agreed,21 
but no similar attempt has been made for Rho/Rac GAPs. In 
this study we first prepared a similar nomenclature table for 
75 human Rho family GAPs containing the official names 
and other aliases used in previous studies and abbreviations 
from different databases. As additional information we pres-
ent the pylogenetic tree and the domain structure of 65 human 
RhoGAPs. Subsequently we analyzed the tissue-distribution of 
54 GAPs in healthy and in cancerous tissues based on expressed 
sequence tag (EST) database and finally we show the tissue-
expression of 45 human Rho family GAP genes in microarray 
database.
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Results
Nomenclature of human Rho family GAP genes. The nomen-
clature of the approximately 70 Rho/Rac GAP proteins is quite 
diverse. Some well-known members (ABR, BCR, p190RhoGAP) 
are mostly cited with their conventional names; however, the dif-
ference between the original and the conventional names might 
lead to confusion. For this reason we generated a nomenclature 
table containing 75 potential Rho family GAP genes. Each GAP 
has several names of which only one full name and one abbrevia-
tion are approved as official by the HUGO Gene Nomenclature 
Committee (HGNC) (Table S1, columns 1 and 2). The third 
column of the table contains the names and symbols, which 
were withdrawn by HGNC. In addition, the table shows the 
predicted protein length and the chromosomal localizations. 
We also indicated the most commonly used identification num-
bers as the RefSeq Transcript ID, the Ensembl Gene ID, and 
the Entrez Gene ID from NCBI, the KIAA Number and FLJ 
Number. The last column of the table contains the other symbols 
and aliases which are also found in publications (Table S1). The 
HGNC database contains the official names only of 67 Rho/Rac 
GAPs. The other 7 genes were withdrawn and the gene ID of 
DKFZP434A1010 was replaced. These 8 genes are only indicated 
using the ID from the article of Bernards.12
Based on the amino acid sequence of the GAP domain, we 
prepared a phylogenetic tree of 65 human Rho/RacGAPs (Fig. 1) 
and the domain structure of these 65 GAPs was drawn (Fig. 2).
Expression profile of human Rho/Rac GAPs based on EST 
database. We identified 54 human Rho family GAPs in the EST 
database. Their frequency of appearance in the analyzed tissues is 
presented in a color table containing the identified GAPs and 45 
different healthy tissue types (Table 1). This frequency is propor-
tional to the expression levels and was symbolized with a color-
coded scale from dark blue to red colors. Warm colors represent 
high expression frequencies and cold colors represent low mRNA 
levels.
Analyzing the different tissue types, it is remarkable that all 
investigated tissues express multiple GAPs. The largest num-
ber (more than 50) of different GAPs was found in the brain, 
eye, kidney, lung, placenta, testis and uterus. The other tissues 
express Rho/Rac GAPs at a moderate or lower number; however 
even the lowest expression amounts to 9 different GAPs in the 
umbilical cord (Table 1). Interestingly, there are only few tissues 
that express one specific GAP at prominent frequency: on our 
numerical scale only 10 tissues express a GAP at a level higher 
than 500 TPM and the value of 1000 is reached only in two tis-
sues (ARHGAP4 in bone marrow and ARHGAP9 in the spleen) 
(Table 1).
Investigating the individual GAPs, ABR, BCR and SH3BP1 
are the most ubiquitously expressed (in 40 or more tissues). A 
remarkably widespread appearance was observed also in the case 
of ARHGAP5, ARHGAP17, BNIP2, GRLF1 and PIK3R1 that 
are expressed in 36 to 39 tissues. In contrast to the ubiquitous 
GAPs, there are several GAPs with more specific expression. 
ARHGAP36 is present only in 11 of the 45 examined tissues; 
however, it reaches very high level in the pituitary gland. ARAP2 
was found only in 17 tissues but showed very high frequency in 
the stomach. HMHA1 is lymph-specific, and ARHGAP9 and 
ARHGAP25 were found in the blood and spleen in high fre-
quency, with ARHGAP9 reaching the peak expression frequency 
among all investigated Rho family GAPs (Table 1).
Human Rho/Rac GAPs in cancer tissues. We also investi-
gated the EST-cancer database to reveal the approximate amount 
of human Rho family GAPs in cancer tissues. We observed 
that the GAP-frequency was very diverse in the 26 tumor tis-
sues (Table 2). Most of the 54 investigated GAPs are widely 
present and are represented with high frequency. However, 
ARHGAP20, ARHGAP36, ARHGAP39, ARHGAP42 and 
STARD8 showed very low expression frequency in each tissue. 
Interestingly, ARAP2 is specific for esophageal tumor (Table 2), 
which may be associated with its high amount in the stomach 
(Table 1). In contrast, ARHGAP4 and ARHGAP9 show signifi-
cant expression in kidney tumor (Table 2), whereas the healthy 
kidney expresses these genes in low amount (Table 1). CHN1 
showed extremely high frequency in head and neck tumors and 
in lymphomas. Investigating the different tissues we found that 
adrenal tumor, bladder, breast tumor and colorectal tumor con-
tain the least amount of Rho family GAPs. In kidney tumor 
ABR, ARHGAP4, ARHGAP9 and MYO9B are the dominant 
GAPs. The other tumor tissues express Rho/Rac GAPs in aver-
age amount (Table 2).
Comparative analysis of EST data from healthy and tumor 
tissues. We compared the data of 53 human Rho/Rac GAPs 
from 12 healthy and tumor tissues. We selected the tissues that 
were clearly equivalent in the 2 EST data sets. Color-coded scale 
was used to represent the expression frequency of the individual 
GAPs. In the EST data from healthy tissues we found 11 GAPs, 
which showed remarkable expression frequency (from green 
to red colors). The other GAPs have low expression, which is 
shown in blue color (Fig. 3A). In the equivalent tumor tissues 
we observed increased GAP frequency compared with healthy 
tissues (Fig. 3B). We found approximately 20 GAPs, which 
were characterized with marked expression frequency (green to 
red colors) and 3 GAPs exceeded the 250 TPM value (Fig. 3B) 
whereas in the healthy tissues the maximal TPM value was less 
than 250 (Fig. 3A).
Expression profile of human Rho family GAPs based on 
microarray database. We identified 45 human Rho/Rac GAP 
genes in different public microarray databases. Their expression 
level (normalized to GAPDH expression) is shown in 14 healthy 
tissues and in 5 different leukocyte cell types (Table 3). The 
expression values were represented with a color code similar to 
the EST tables. Blue color shows the low mRNA level and red 
color indicates the high expression. Moderate expression levels 
are symbolized with intermediate colors. Evaluating the table we 
found, that several GAPs are present in most of the investigated 
tissues. BCR, ARAP1, PIK3R1, ARHGAP9 and MYO9A and B 
show moderate expression in all tissues and cell types. OPHN1 is 
also present in all tissues; however, its mRNA level is extremely 
high in B cells and NK cells. The widely expressed ARHGAP17 
also shows dominant mRNA level in B cells. ARHGAP10, 
ARHGAP25, ARHGAP26 and HMHA1 are mainly present 
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in leukocytes; however, ARHGAP26 is not expressed in B cells. 
RALBP1, ARHGAP11A, SRGAPs, ARHGAP28, ARHGAP22 
and INPP5B are not present in the investigated tissues and cells 
(Table 3). From all investigated tissues, skeletal muscle contains 
the least amount of GAPs. The other tissues have variable GAP 
repertoire. In white blood cells, the mRNA level of leukocyte-
specific GAPs is very high, but the cells express average number 
of different Rho/Rac family GAPs (Table 3).
We analyzed separately the two neutrophil samples 
(GSM90843 and GSM90844) and we observed high correla-
tion between the two parallel samples. After linear regression 
the R square was 0.9744684774 (Fig. 4), Pearson Correlation 
Coefficient was 0.987 (p = 6.921E-036) and Spearman 
Correlation Coefficient was 0.913 (p = 0.0000002). The good 
correlation between the two parallel samples supports the cred-
ibility of the data.
Correlation analysis of EST and microarray data. The iden-
tical tissues and Rho/Rac GAPs found both in EST and micro-
array data sets were collected and we calculated the correlation 
between the 2 different databases. We examined 41 GAPs and 
12 tissues and we indicated both the Pearson and the Spearman 
Correlation coefficients in Table 4. Significant correlation was 
found in the brain, in the spleen and in the adrenal. In the case 
of lung only the linear dependence was significant which was rep-
resented by the Pearson correlation coefficient (Table 4). In the 
case of the other 9 tissues, we found no significant correlation. 
Figure 5 shows the linear regression between the EST and micro-
array data. We identified good relationship between the two data 
sets in the brain (r2 = 0.82293); however, no statistically signifi-
cant linear relationship was obtained in the other tissues (Fig. 5).
Discussion
The HUGO Gene Nomenclature Committee proposes to assign 
only one name and one abbreviation to each gene. It is recom-
mended, because it simplifies the database- and literature search. 
It is worth to note that most of the computer databases (e.g., 
EntrezGene) search in their stored data using the HGNC nomen-
clature. However, in the case of Rho family GAPs, the most com-
monly used name is not always the same as the official name. 
Highlighting an example, the widespread name of GRLF1 (the 
official name is ARHGAP35 according to HGNC) is p190A. 
Figure 1. Phylogenetic tree of human Rho family GAPs. Partial protein sequences (~100 aa) of the GAP domain of 65 human Rho/Rac GAPs were 
aligned with ClustalW. Reconstruction of the unrooted tree was performed with distance matrix analysis on Mobyle portal in the following order: 
PROTDIST (Categories model) followed by FITCH (Global rearrangements).
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Searching for GRLF1 in NCBI PubMed database (www.ncbi.
nlm.nih.gov/pubmed/) results in 108 findings containing also 
recent articles such as the one published in 2012 February.22 In 
contrast, searching with the term “p190A” gives only 14 results 
and the article of Warren et al.22 is among the many references 
that do not show up. Interestingly, searching for its official name 
ARHGAP35 gives 69 results. This makes it indispensable to 
standardize the nomenclature of human Rho family GAPs. Our 
compiled table proposes a common nomenclature for 67 GAPs 
according to HGNC and provides additional helpful information 
for database search. We also found 8 Rho family GAPs identi-
fied by A. Bernards,12 which have no official HGNC name yet 
(Table S1).
The large number of Rho family GAPs suggests that different 
tissue- and cell-types express their own GAP repertoire. This is 
substantiated by the complex domain structure of the individual 
GAPs, which allows their specific regulation and participation in 
large molecular complexes. However, only scarce information is 
available on the tissue distribution of GAPs. To reveal the expres-
sion of human Rho family GAPs in different tissues, we started 
to analyze EST and microarray databases (Tables 1–3). Our find-
ings significantly extend the existing knowledge. For example, 
previous studies identified p250GAP (see ARHGAP32 in our 
tables), which is specific for neuronal tissues.23,24 In agreement 
with these data, we found the highest expression of ARHGAP32 
in nerve tissue, but we also observed high expression frequency 
in the bladder, ear, eye, mammary gland or in the stomach 
(Table 1). BCR was shown to play important role in the regu-
lation of synaptic Rac1 activity, in the development of the ves-
tibular apparatus25,26 and in immunological processes such as the 
Figure 2. Domain structure of human Rho/Rac GAPs. Abbreviations for domains are as follows: A, alanine-rich; BAR, Bin/amphiphysin/Rvs; C1, 
cysteine-rich phorbol ester binding; C2, calcium-dependent lipid binding; CC, coiled-coil; CRAL-TRIO, cellular retinaldehyde and TRIO domain; FCH, 
Fes/CIP4 homology; FF, contains two conserved phenylalanine residues; G, glutamine-rich; IQ, calmodulin-binding motif; Myhl2, myosin head-like 2; 
MyTH4, myosin tail homology 4; P, proline-rich; PDZ, protein binding site; PH, pleckstrin homology; PX, Phox homology; RA, Ras association (RalGDS/
AF-6) domain; S, serine-rich; S/T kinase, serine/threonine kinase; SAM, sterile α motif; SH2, Src Homology 2; SH3, SRC Homology; 3START, StAR-related 
lipid transfer; WW, two highly conserved tryptophans (in purple). Arrowheads with numbers indicate the position of the catalytic arginine residue in 
the RhoGAP domain. SH3-binding domain (in blue).
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regulation of the activity of the phagocytic NADPH oxidase27 
and controlling macrophage functions.28,29 In accordance with 
these reports, high expression frequency for BCR was found in 
the blood, in the brain, in the spleen and in the lymph node 
(Table 1). However, our data indicate that BCR is a ubiquitous 
protein present in high amount also in the adipose tissue, in 
the skin (Table 1) and in B and NK cells (Table 3). We pre-
viously described ARHGAP25 as the regulator of phagocytosis 
in human neutrophils.30 In silico data suggested that this GAP 
is present in high amount in the blood, in the spleen (Table 1) 
and in hematopoietic cells (Table 3). We confirmed these data 
by Northern and western blot analysis. This finding helped us to 
reveal the physiological function of ARHGAP25.
However, comparative analysis of EST and microarray data 
revealed the conceptual differences between these data sets. EST 
indicates how many times can be detected a gene in a tissue type 
which means the expression frequency of the gene in the inves-
tigated tissue, disregarding of the expression level.31 In contrast, 
microarray data provide information on the real mRNA amount 
using a hybridization method. We found, that in the case of 
human Rho/Rac GAPs the two databases are not equivalent. We 
observed good correlation between EST and microarray only in 
the brain, in the spleen and in the adrenal. For the other tissues 
we found no correlation (Fig. 5; Table 4). Within one database 
or between similar databases data are well comparable, as dem-
onstrated by the example of the two separate samples from neu-
trophils (Fig. 4). However, as our data demonstrate, EST and 
microarray databases provide different type of information and 
should be regarded as complementary source of information.
Analysis of healthy and tumor tissues from EST revealed that 
the expression frequency of some GAPs was increased in tumor 
tissues (Fig. 3). The role of Rho family small G-proteins and 
GAPs in cancer phenotype and in tumor cell migration has been 
documented.32-36
Taken together, in this study we suggest the application of a 
common nomenclature for 67 human Rho family GAPs according 
Table 1. Expression profile of human Rho family GAPs based on EST database
Expression levels are indicated with color scale, which is proportional to transcript per million values indicating by numbers. Blue, low expression; red, 
high expression.
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Table 2. Expression profile of human Rho family GAPs based on EST tumor database
Expression levels are indicated with color scale, which is proportional to transcript per million values indicating by numbers. Blue, low expression; red, 
high expression.
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Table 3. Expression profile of human Rho family GAPs based on EST tumor database
Expression levels are indicated with color scale. Blue, low expression; red, high expression. Numbers show the mRNA amounts normalized to GAPDH 
(see also Materials and Methods).
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Figure 4. Correlation between two parallel neutrophil samples from 
microarray data. GSM90844 and GSM90843 samples were analyzed by 
linear regression. R square is indicated. Pearson Correlation Coefficient 
= 0.987, p = 6.921E-036. Spearman Correlation Coefficient = 0.913,  
p = 0.0000002.
Figure 3. Comparative analysis of healthy and tumor tissues from EST database. We investigated 53 human Rho family GAPs and 12 equivalent tissues 
from both healthy and tumor databases. (A) shows the healthy tissues, and (B) shows the tumor tissues. The transcript per million (TPM) values are 
indicated with color-coded scale. Blue color correlates with the low TPM values, which show the low expression frequency of GAPs. Warm colors are 
proportional to higher expression frequencies.
to HGNC. In order to make data-mining easier, we collected the 
abbreviations, names, symbols, and other IDs used until now. 
We also assembled the expression profiles of these genes accord-
ing to EST database and microarray experiments, which can be 
helpful to identify GAPs in hitherto unknown tissue-specific 
function.
Materials and Methods
Nomenclature of human Rho family GAPs. The identification 
of the potential Rho/Rac GAPs was based on previous data12 
and available public databases (Table 5). The table contain-
ing the nomenclature information (Table S1) was prepared by 
Microsoft® Office Excel® 2007 SP2 software.
Phylogenetic analysis. The amino acid sequences of 65 human 
RhoGAP domains from UniProt/Swissprot (http://www.uni-
prot.org) were aligned and edited applying the ClustalW program 
incorporated to MEGA5 software using Gonnet protein weight 
matrix. Distance matrix analysis was performed with Mobyle 
portal (mobyle.pasteur.fr/cgi-bin/portal.py) in the following 
order: PRODIST (Categories amino acid substitution model) 
followed by FITCH (Global rearrangements). Phylogenetic tree 
was visualized and edited by FigTree v1.3.1.
EST database search. Expressed sequence tag (EST) database 
is a cDNA library that contains short sequences of different genes 
and is used to identify gene transcripts.31 Transcript per million 
(TPM) values of EST provide information about the frequency 
of genes in different tissues and represent the approximate expres-
sion levels of the investigated genes. EST profiles of 54 human 
Rho family GAP genes (http://www.ncbi.nlm.nih.gov/unigene) 
were searched and analyzed. TPM values were sorted by body 
sites and by health state (healthy vs. tumor tissues) and were sum-
marized in color-scaled tables. The initial point of the scale bar, 
which was labeled with blue color, is the minimum TPM value of 
the table. The maximum value of the table that summarizes data 
of healthy tissues is 1498 whereas the maximum TPM value for 
tumor tissues is 861. These were set as the end points of the scale 
bars and labeled with red. The intermediate TPM values were 
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experiments GDS1209 (http://www.ncbi.nlm.nih.gov/sites/
GDSbrowser?acc=GDS1209)37,38 and GSE3982 (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE3982)39 were 
performed with Affymetrix Human Genome U133A array 
and were obtained from PubMed GEO DataSets database 
(http://www.ncbi.nlm.nih.gov/gds). Two separate experiments 
labeled with the intermediate colors. Tables and scale bars were 
prepared using Microsoft® Office Excel® 2007 SP2 software.
Microarray database search. Compared with EST, micro-
array database contains individual experiments prepared with 
DNA chip array technique and gives information about the 
real expression levels of the investigated genes. The analyzed 
Figure 5. Correaltion between EST and microarray data. We analyzed 12 equivalent tissue types and 41 GAPs from both databases. R square calculated 
with linear regression is indicated. Correlation coefficients and p values are found in Table 4.
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microarray data was prepared by Microsoft® Office Excel® 2007 
SP2 software.
Statistical analysis. Correlation analysis was performed with 
SigmaPlot 11.0 software. Correlation coefficients and p values 
were calculated using the Pearson Product Moment Correlation 
Table  5. Sources of abbreviations and aliases of human Rho/Rac GAPs
Original source (abbreviation) Link
Approved symbol HUGO Gene Nomencature Committee (HGNC) http://www.genenames.org/
Approved name HUGO Gene Nomencature Committee (HGNC) http://www.genenames.org/
Previous symbols HUGO Gene Nomencature Committee (HGNC) http://www.genenames.org/
Sequence lenght (amino acids) UniProt Protein Knowledgebase (UniProt KB) http://www.uniprot.org/
Chromosomal location HUGO Gene Nomencature Committee (HGNC) http://www.genenames.org/
RefSeq Transcript ID National Center for Biotechnology Information (NCBI) http://www.ncbi.nlm.nih.gov/gene/
Ensembl Gene ID Ensembl Genome Browser http://www.ensembl.org/index.html
Entrez Gene ID National Center for Biotechnology Information (NCBI) http://www.ncbi.nlm.nih.gov/gene
KIAA Number Kazusa cDNA Sequencing Project http://www.ihop-net.org/UniPub/iHOP/
FLJ Number NEDO Human cDNA Sequencing Project http://www.ihop-net.org/UniPub/iHOP/
Other aliases
Information Hyperlinked Over Proteins (iHOP) HUGO 
Gene Nomenclature Committee (HGNC), GeneCards
http://www.ihop-net.org/UniPub/iHOP/ 
http:// www.genenames.org/
Table 4. Correlation between EST and microarray data
Tissue type Parameters calculated Pearson product moment correlation Spearman rank order correlation
brain
correlation coefficient 0.907 0.44
p value 3.04E-16 0.00414
spleen
correlation coefficient 0.438 0.426
p value 0.00417 0.0057
kidney
correlation coefficient -0.0309 0.0221
p value 0.848 0.89
liver
correlation coefficient 0.216 0.192
p value 0.176 0.227
lung
correlation coefficient 0.365 0.123
p value 0.0188 0.44
intestine
correlation coefficient 0.0828 0.225
p value 0.607 0.156
muscle
correlation coefficient 0.0543 0.237
p value 0.736 0.135
stomach
correlation coefficient -0.108 0.0212
p value 0.501 0.894
pancreas
correlation coefficient 0.202 0.339
p value 0.205 0.0306
prostate
correlation coefficient 0.302 0.411
p value 0.0551 0.0079
skin
correlation coefficient 0.071 0.166
p value 0.659 0.297
adrenal
correlation coefficient 0.373 0.327
p value 0.0163 0.0369
containing inter alia two different neutrophil samples were ana-
lyzed. The experiment and sample IDs are presented in Table 6. 
The expression levels were normalized to GAPDH. We used the 
color scale bar described above. The initial point was 0 (blue) 
and the end point was 2.2488 (red). The table containing the 
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and Spearman Rank Order Correlation. 
We analyzed only those tissues and GAPs 
which were found in both evaluated data 
sets.
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Table 6. The analyzed samples of microarray experiments
Experiment GDS1209 GSE3982
Sample
GSM52556 (brain)
GSM52557 (connective tissue)
GSM52569 (skeletal muscle)
GSM52570 (spleen)
GSM52557 (stomach)
GSM52568 (lung)
GSM52558 (rectum)
GSM52559 (pancreas)
GSM52560 (prostate)
GSM52561 (skin)
GSM52562 (small intestine)
GSM52563 (adrenal)
GSM52566 (kidney)
GSM52567 (liver)
GSM90843 (neutrophilic granulocyte 1)
GSM90844 (neutrophilic granulocyte 2)
GSM90838 (macrophage)
GSM90845 (B cell)
GSM90851 (NK cell)
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